Rubicon Research Limited (NSE:RUBICON)
India · Delayed Price · Currency is INR 650.05
-14.55 (-2.19%)
At close: Jan 23, 2026
Rubicon Research Revenue
Rubicon Research had revenue of 4.12B INR in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to 14.36B. In the fiscal year ending March 31, 2025, Rubicon Research had annual revenue of 12.84B with 50.40% growth.
Revenue (ttm)
14.36B
Revenue Growth
+50.40%
P/S Ratio
7.46
Revenue / Employee
15.90M
Employees
903
Market Cap
107.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 12.84B | 4.30B | 50.40% |
| Mar 31, 2024 | 8.54B | 4.60B | 116.99% |
| Mar 31, 2023 | 3.94B | 799.52M | 25.50% |
| Mar 31, 2022 | 3.14B | -11.49M | -0.37% |
| Mar 31, 2021 | 3.15B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jubilant Pharmova | 76.18B |
| Granules India | 48.42B |
| J. B. Chemicals & Pharmaceuticals | 41.93B |
| FDC Limited | 20.77B |
| Caplin Point Laboratories | 20.42B |
| AstraZeneca Pharma India | 20.06B |
| Sanofi India | 19.33B |
| Viyash Scientific | 16.58B |